Furthermore, periodic acid‐Schiff (PAS) staining indicated decreased mucus production in the nasal mucosa and lungs post‐treatment with PG1, B‐PM, DNase I, and Dex, which is beneficial to alleviate the overgeneration of snot and sputum of patients with rhinosinusitis or asthma. This evidence concerns the gene DNASE1 and common cold.